Patent application number | Description | Published |
20110274256 | VOICEMAIL MODULE - A voicemail module is described, which module is intended to be incorporated into a voicemail system of one or more end users. The voicemail module includes a plurality of settings, some of which may be provided by the developer and some of which may be provided by the end user. For at least some of the settings that are provided by the developer, a flag or some other mechanism is provided for indicating whether the developer allows the end user to modify the setting. Thus, a flexible voicemail module is provided that enables the developer of the module to retain control of the aspects of the module that can be configured by the end user. | 11-10-2011 |
20110274263 | VOICEMAIL APPLICATION - An application is described, which application detects that a communication device of a called party is not accepting a call from a calling party and initiates a voicemail application in response to the detecting step. The voicemail application includes a plurality of voicemail modules, each of which is a complete and functional voicemail application. The initiation of the voicemail application includes selecting one of said plurality of possible voicemail modules for use, for example on the basis of the identity (or some other characteristic) of the calling party and/or the identity (or some other characteristic) of the called party. | 11-10-2011 |
20110275351 | MOBILE VOICEMAIL APPLICATION - An arrangement is provided for detecting that a called party is not (or is not able) to accept an incoming call, such that a voicemail application should be initiated. In response to this detection, a premium voicemail service is initiated, for example by a SIP server that does not typically form part of the mobile operator of the called party. The premium voicemail service selects one of a number of available voicemail services, typically dependent on the identity of the called party and/or the calling party and provides that voicemail service. The voicemail service(s) offered by the premium voicemail service are user-definable. For example, the user may be able to purchase a particular voicemail service, modify and existing voicemail service and/or design a voicemail service. | 11-10-2011 |
20110276952 | TELECOMMUNICATIONS APPLICATION GENERATOR - An arrangement for generating a telecommunications application (such as a voicemail application) is described. The arrangement provides a graphical user interface that enables a user to select telecommunications application building blocks and to position and connect those blocks on the display in order to define an algorithm. The algorithm can be implemented using pre-defined modules for said building blocks. | 11-10-2011 |
20130117729 | TELECOMMUNICATIONS APPLICATION GENERATOR - An arrangement for generating a telecommunications application (such as a voicemail application) is described. The arrangement provides a graphical user interface that enables a user to select telecommunications application building blocks and to position and connect those blocks on the display in order to define an algorithm. The algorithm can be implemented using pre-defined modules for said building blocks. | 05-09-2013 |
Patent application number | Description | Published |
20080300276 | Heterocyclic Carboxylic Acide Amide Derivatives - The invention relates to new heterocyclic carboxylic acid amide derivatives of formula (I)—wherein the meaning of X is hydrogen or halogen atom, hydroxy, cyano, C | 12-04-2008 |
20080312222 | 4-Benzyledene-Piperidin Derivatives - The present invention relates to new 4-benzylidene-piperidin derivatives of formula (I), useful as NMDA, in a particular NR2B subunit containing receptor antagonists and analgesica. | 12-18-2008 |
20090012118 | Kynurenic Acid Amide Derivatives as Nr2b Receptor Antagoni - The new kynurenic acid amide derivatives of formula (I): and optical antipodes, racemates and the salts thereof are highly effective and selective antagonists of NMDA receptor, and moreover most of the compounds are selective antagonist of NR2B subtype of NMDA receptor. | 01-08-2009 |
20090048303 | Indole-2-carboxamidine derivatives as nmda receptor antago - The present invention relates therefore first to new indole-2-carboxamidine derivatives of formula (I)—wherein the meaning of X is hydrogen or halogen atom, C | 02-19-2009 |
20090170901 | Benzoyl Urea Derivatives - The new benzoyl urea derivatives of formula (I) wherein the meaning of X and Y independently are hydrogen atom, hydroxy, benzyloxy, amino, nitro, C | 07-02-2009 |
20090205356 | Cabinet refrigerating system - The present invention relates to a refrigerated air supply system ( | 08-20-2009 |
Patent application number | Description | Published |
20090018337 | PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL INTERMEDIATE - The present invention relates to a process for the preparation of {2-[4-(α-phenyl-p-chlorobenzyl)-piperazin-1-yl]-ethoxy}-acetic acid-N,N-dimethylamide of the Formula (I) and enantiomers thereof. The compound of the Formula (I) or enantiomers thereof are important pharmaceutical intermediates suitable for direct transformation into non-sedating antihistamine type pharmaceutical active ingredients cetirizine and levocetirizine. | 01-15-2009 |
20090137563 | PROCESS FOR THE PREPARTION OF OLANZAPINE - The invention relates to a process for the preparation of 2-methyl-4-(4-methylpiperazin-1-yl)-10H-thieno-[2,3-b][1,5]benzodiazepine (olanzapine) of the formula (I) by reacting 4-amino-2-methyl-10H-thieno [2,3-b][1/5]benzodiazepine hydrochloride of the formula (II) with N-methylpiperazine in an organic solvent, which comprises carrying out the reaction in the mixture of toluene and 1,3-dimethyl-2-imidazolidinone. The invention also encompasses new 2-methyl-4-(4-methylpiperazin-1-yl)-10H-thieno [2,3-b][1,5]benzodiazepine dihydrochloride trihydrate of the formula (IB), the preparation thereof and pharmaceutical compositions comprising said new compound. | 05-28-2009 |
20090215757 | Process for Preparation of High-Purity Meloxicam and Meloxicam Potassium Salt - The invention provides a process for the preparation of high purity meloxicam of the Formula (II). The meloxicam raw product is reacted with the solution of potassium hydroxide or potassium carbonate, whereby high purity meloxicam potassium salt monohydrate is produced. Said salt is subsequently treated with mineral or organic acid to yield high-purity meloxicam. | 08-27-2009 |
20090221823 | OPTICALLY ACTIVE CARBAMATES, PROCESS FOR PREPARATION THEREOF AND USE THEREOF AS PHARMACEUTICAL INTERMEDIATES - The present invention is related to 1-[(4-chlorophenyl)-phenylmethyl]-4-(2,2,2-trichloroethoxycarbonyl)-piperazine of the Formula (IV) and optically isomers thereof, process for preparation thereof and the use of the compound of the Formula (IV) in the preparation of 1-(4-chlorophenyl)-phenylmethyl-piperazine and optical isomers and salts thereof. 1-(4-chlorophenyl)-phenylmethyl-piperazine and optical isomers thereof are important intermediates in the preparation of non-sedating antihistamine-type active pharmaceutical ingredients. | 09-03-2009 |
20090221853 | PROCESS FOR THE PREPARATION OF 2-CHLOROETHOXY-ACETIC ACID-N,N-DIMETHYLAMIDE - According to the present invention, 2-chloroethoxy-acetic acid-N,N-dimethylamide of the Formula (I) is prepared by reacting 2-hydroxyethoxy-acetic acid-N,N-dimethylamide of the Formula (II) in a solvent optionally in the presence of a catalyst with thionyl chloride and removing the solvent by distillation. | 09-03-2009 |
20120178729 | CRYSTALLINE FORM I ROSUVASTATIN ZINC SALT - The present invention relates to crystalline Form I rosuvastatin zinc (2:1) salt, method of preparation thereof and use thereof as pharmaceutically active ingredient for the treatment of diseases related to lipid metabolism including hyperlipoproteinemia, hypercholesteremia, dyslipidemia and atherosclerosis. | 07-12-2012 |
20120330018 | PROCESS FOR PREPARING PHARMACEUTICAL COMPOUNDS AND INTERMEDIATE COMPOUNDS - The object of the present invention is a process for preparing the 2-acetoxy-5-(2-fluor-α-cyclopropyl-carbonyl-benzyl)-4,5,6,7-tetrahydro-4H-tieno[3,2-c]pyridine (prasugrel) of the formula (I). The process starts form crystalline 5-trityl-4,5,6,7-tetrahydro-tieno[3,2-c]pyridine of the formula (VI). Further objects of the present invention are two novel crystalline forms of 5-trityl-4,5,6,7-tetrahydro-tieno[3,2-c]pyridine of the formula (VI) and the use thereof for preparing the compound of the formula (V) and process preparing thereof. | 12-27-2012 |
20130005790 | INORGANIC SALT COMPLEXES OF VILDAGLIPTIN - The present invention relates to the use of novel vildagliptin complexes for the manufacture of high purity vildagliptin of Formula I and/or pharmaceutical acceptable salts thereof. Further objects of the present invention are pharmaceutically acceptable complexes of vildagliptin and/or amorphous and crystalline forms, anhydrous forms, amorphous and crystalline hydrates, amorphous and crystalline solvates of the complexes and a process for the preparation thereof. Another object of the present invention is the high purity vildagliptin and pharmaceutically acceptable salts thereof prepared form the vildagliptin complexes of the present invention, a process for the preparation thereof and pharmaceutical compositions containing vildagliptin base, pharmaceutically acceptable salts and/or complexes and use thereof for the treatment of type 2 diabetes (NIDDM). The present invention provides pharmaceutically advantageous high purity vildagliptin complexes. | 01-03-2013 |
20130030183 | PROCESS FOR PREPARING A PHARMACEUTICAL COMPOUND - The object of the present invention is a one-pot process for preparing the 2-acetoxy-5-(2-fluoro-α-cyclopropyl-carbonyl-benzyl)-4,5,6,7-tetrahydro-4H-tieno[3,2-c]-pyridine (prasugrel) of the formula (I) by reacting the 5,6,7,7a-tetrahydro-4H-tieno[3,2-c]-pyridine-2-on of the formula (II) with 2-bromo-1-cyclopropyl-2-(2-fluorophenyl)-etanone of the formula (III) or with 2-chloro-1-cyclopropyl-2-(2-fluorphenyl)-etanone of the formula (IIIa) and acetylating of the formed compound of the formula (IV), wherein the reaction is carried out in the presence of an organic base with an acetylation agent without isolating the compound of the formula (IV). The coupling and acetylation are carried out in the presence of the same organic base such as triethylamine, N,N-diisopropyl-ethylamine or pyridine. At the end of the process the prasugrel of the formula (I) is purified by recrystallization from an organic solvent or a mixture of solvents. | 01-31-2013 |
20130225695 | METHOD FOR PREPARATION OF AN EXCIPIENT SUITABLE FOR PHARMACEUTICAL USE - The present invention is related to a method for purifying diatomaceous earth wherein the natural colloidal structure of the material is retained, which comprises preparing a suspension of diatomaceous earth in a liquid wherein diatomaceous earth is insoluble, separating diatomaceous earth from the suspension, treating diatomaceous earth with an inorganic or organic acid, heat-treating the thus obtained product at a temperature not higher than 300° C., subjecting the product obtained to oxidative treatment and drying the purified product. | 08-29-2013 |
20130338360 | METHOD FOR THE PREPARATION OF HIGH-PURITY PHARMACEUTICAL INTERMEDIATES - The present invention is related to intermediates useful in the preparation of pharmaceutically acceptable salts of (+)-7-[4-(4-fluorophenyl)-6-isopropyl-2-(methanesulfonyl-methyl-amino)-pyrimidin-5-yl]-(3R,5S)-dihydroxy-hept-6-enoic acid and polymorphs of said intermediates, methods for preparation thereof and use thereof. | 12-19-2013 |
Patent application number | Description | Published |
20090215757 | Process for Preparation of High-Purity Meloxicam and Meloxicam Potassium Salt - The invention provides a process for the preparation of high purity meloxicam of the Formula (II). The meloxicam raw product is reacted with the solution of potassium hydroxide or potassium carbonate, whereby high purity meloxicam potassium salt monohydrate is produced. Said salt is subsequently treated with mineral or organic acid to yield high-purity meloxicam. | 08-27-2009 |
20120035162 | PROCESS FOR PREPARATION OF HIGH-PURITY MELOXICAM AND MELOXICAM POTASSIUM SALT - The invention provides a process for the preparation of high purity meloxicam of the Formula (II). The meloxicam raw product is reacted with the solution of potassium hydroxide or potassium carbonate, whereby high purity meloxicam potassium salt monohydrate is produced. Said salt is subsequently treated with mineral or organic acid to yield high-purity meloxicam. | 02-09-2012 |
20120330018 | PROCESS FOR PREPARING PHARMACEUTICAL COMPOUNDS AND INTERMEDIATE COMPOUNDS - The object of the present invention is a process for preparing the 2-acetoxy-5-(2-fluor-α-cyclopropyl-carbonyl-benzyl)-4,5,6,7-tetrahydro-4H-tieno[3,2-c]pyridine (prasugrel) of the formula (I). The process starts form crystalline 5-trityl-4,5,6,7-tetrahydro-tieno[3,2-c]pyridine of the formula (VI). Further objects of the present invention are two novel crystalline forms of 5-trityl-4,5,6,7-tetrahydro-tieno[3,2-c]pyridine of the formula (VI) and the use thereof for preparing the compound of the formula (V) and process preparing thereof. | 12-27-2012 |
20130030183 | PROCESS FOR PREPARING A PHARMACEUTICAL COMPOUND - The object of the present invention is a one-pot process for preparing the 2-acetoxy-5-(2-fluoro-α-cyclopropyl-carbonyl-benzyl)-4,5,6,7-tetrahydro-4H-tieno[3,2-c]-pyridine (prasugrel) of the formula (I) by reacting the 5,6,7,7a-tetrahydro-4H-tieno[3,2-c]-pyridine-2-on of the formula (II) with 2-bromo-1-cyclopropyl-2-(2-fluorophenyl)-etanone of the formula (III) or with 2-chloro-1-cyclopropyl-2-(2-fluorphenyl)-etanone of the formula (IIIa) and acetylating of the formed compound of the formula (IV), wherein the reaction is carried out in the presence of an organic base with an acetylation agent without isolating the compound of the formula (IV). The coupling and acetylation are carried out in the presence of the same organic base such as triethylamine, N,N-diisopropyl-ethylamine or pyridine. At the end of the process the prasugrel of the formula (I) is purified by recrystallization from an organic solvent or a mixture of solvents. | 01-31-2013 |
20130225695 | METHOD FOR PREPARATION OF AN EXCIPIENT SUITABLE FOR PHARMACEUTICAL USE - The present invention is related to a method for purifying diatomaceous earth wherein the natural colloidal structure of the material is retained, which comprises preparing a suspension of diatomaceous earth in a liquid wherein diatomaceous earth is insoluble, separating diatomaceous earth from the suspension, treating diatomaceous earth with an inorganic or organic acid, heat-treating the thus obtained product at a temperature not higher than 300° C., subjecting the product obtained to oxidative treatment and drying the purified product. | 08-29-2013 |
Patent application number | Description | Published |
20090126821 | HIGH-PRESSURE RUBBER HOSE AND METHOD AND APPARATUS FOR PRODUCING THE SAME - The object of the invention is a high-pressure rubber hose comprising a liner ( | 05-21-2009 |
20110041985 | METHOD AND APPARTUS FOR MANUFACTURING FIBRE-REINFORCED HOSES - The object of the invention is a method for building hoses reinforced with spirally laid fibres, where the hose under construction ( | 02-24-2011 |
20110068572 | SWAGED COUPLING FOR HIGH-PRESSURE HOSE, HIGH-PRESSURE HOSE WITH SWAGED COUPLING, AND METHOD FOR MAKING THE SAME - A hose coupling for high-pressure hoses includes a stem and a ridged outer ferrule connected to the stem, wherein a staggered portion is disposed on the stem in the proximity of the connection of the stem and the ridged outer ferrule, where the diameter of the staggered portion is larger than the diameter of the stem, and the staggered portion has an undercut and a cutting edge. Also, a high-pressure hose fitted with the above swaged coupling, and a method for producing it. In the method, prior to swaging, the cover of the hose is removed at the portion where the cover is in connection with the ridges of the ridged outer ferrule of the hose coupling, and the hose liner and an optionally included load distribution textile ply or cord fabric ply are also removed from the hose end before swaging at a length not longer than the length of the staggered portion of the stem. | 03-24-2011 |
20140261845 | BONDED HIGH-PRESSURE RUBBER HOSE, PARTICULARLY FOR CONVEYING GASEOUS MEDIA - The invention relates to a bonded high-pressure rubber hose comprising a flexible internal stripwound tube ( | 09-18-2014 |
20160003381 | FLEXIBLE METAL PIPE, METHOD AND APPARATUS FOR PRODUCING THE SAME, AND HOSE COMPRISING THE FLEXIBLE METAL PIPE - The invention relates to a flexible metal pipe spirally wound from profiled metal strips, wherein the width of the strip profiles is greater than the axial pitch measured at the direction of the principal axis of the flexible metal pipe, and the profiles may slide over one another as the flexible metal pipe is bent the essential feature of the invention being that the strip profile is made from at least two substantially or partially overlapping strips ( | 01-07-2016 |